“Efficacy and Safety of CD19-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy in Refractory Systemic Lupus Erythematosus: A Systematic Review of Clinical Outcomes and B-Cell Depletion Kinetics”, AMCR, vol. 7, no. 1, pp. 1–18, Dec. 2025, doi: 10.37275/amcr.v7i1.831.